BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Prostate
,
Avian flu virus
,
Quercetin
,
rs2476601
,
ERBB2
,
Metabolism of xenobiotics
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
platelet derived growth factor receptor tyrosine kinase
Summary
General Info
Curated Studies
Most Correlated Studies
L1000 CMAP - Adenocarcinoma of breast MCF7 cells treated with ligand perturbagens
L1000 CMAP - Amelanotic malignant melanoma of skin A375 cells treated with ligand perturbagens
L1000 CMAP - Prostate carcinoma VCaP cells treated with ligand perturbagens
L1000 CMAP - Lung cancer A549 cells treated with ligand perturbagens
L1000 CMAP - Colorectal cancer HT29 cells treated with ligand perturbagens
Explore Curated Studies Results
Literature
Most Relevant Literature
Discovery of High-Affinity PDGF-VEGFR Interactions: Redefining RTK Dynamics.
Platelet-derived growth factor-BB: a stimulus for cytokine production by orbital fibroblasts in Grav…
Effects of KTJ740, a novel antithrombotic agent, on platelet-derived growth factor-induced rat aorti…
Coagulation factor Xa synergistically interacts with serotonin in inducing vascular smooth muscle ce…
Efficacy of the novel selective platelet-derived growth factor receptor antagonist CT52923 on cellul…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Impact of the Inhibitors of Tyrosine Kinase on the Male Fertility
Anlotinib Hydrochloride Combined With EGFR-Tyrosine Kinase Inhibitor (TKI) in Treating Advanced NSCL…
Testing the Combination of MLN0128 (TAK-228) and AZD9291 in Advanced EGFR (Epidermal Growth Factor R…
Imatinib Mesylate in Treating Patients With Refractory or Relapsed Ovarian Epithelial, Fallopian Tub…
XL999 Administered Intravenously to a Subject With Advanced Malignancies
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ